# ROPIVACAINE HYDROCHLORIDE

NDC: 67457-798
Generic name: ROPIVACAINE HYDROCHLORIDE
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, INFILTRATION, PERINEURAL
Marketing started: 20240318

FDA application: ANDA206091

## Active ingredients

- ROPIVACAINE HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-798"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-798
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e1d1b15-c224-4ff4-a39d-3b9cebfc8403